nodes	percent_of_prediction	percent_of_DWPC	metapath
Amrinone—TNF—Matrix Metalloproteinases—TIMP3—age related macular degeneration	0.104	0.104	CbGpPWpGaD
Amrinone—TNF—Caspase Cascade in Apoptosis—TNFRSF10A—age related macular degeneration	0.0471	0.0471	CbGpPWpGaD
Amrinone—TNF—Amyotrophic lateral sclerosis (ALS)—CST3—age related macular degeneration	0.0467	0.0467	CbGpPWpGaD
Amrinone—TNF—SIDS Susceptibility Pathways—REST—age related macular degeneration	0.0431	0.0431	CbGpPWpGaD
Amrinone—TNF—Overview of nanoparticle effects—CRP—age related macular degeneration	0.04	0.04	CbGpPWpGaD
Amrinone—TNF—TNF receptor signaling pathway —SQSTM1—age related macular degeneration	0.0326	0.0326	CbGpPWpGaD
Amrinone—TNF—TGF-beta Receptor Signaling—TGFBR1—age related macular degeneration	0.0317	0.0317	CbGpPWpGaD
Amrinone—TNF—Cardiac Hypertrophic Response—TGFBR1—age related macular degeneration	0.0312	0.0312	CbGpPWpGaD
Amrinone—TNF—Apoptosis-related network due to altered Notch3 in ovarian cancer—SQSTM1—age related macular degeneration	0.0291	0.0291	CbGpPWpGaD
Amrinone—TNF—SIDS Susceptibility Pathways—MAP2—age related macular degeneration	0.0247	0.0247	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—F13B—age related macular degeneration	0.0242	0.0242	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—SERPING1—age related macular degeneration	0.0228	0.0228	CbGpPWpGaD
Amrinone—TNF—Aryl Hydrocarbon Receptor—CD36—age related macular degeneration	0.0219	0.0219	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—RAD51B—age related macular degeneration	0.0198	0.0198	CbGpPWpGaD
Amrinone—TNF—IL23-mediated signaling events—CCL2—age related macular degeneration	0.0193	0.0193	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—SLC16A8—age related macular degeneration	0.0184	0.0184	CbGpPWpGaD
Amrinone—TNF—Vitamin B12 Metabolism—CRP—age related macular degeneration	0.0182	0.0182	CbGpPWpGaD
Amrinone—TNF—Vitamin B12 Metabolism—APOE—age related macular degeneration	0.0178	0.0178	CbGpPWpGaD
Amrinone—TNF—TWEAK Signaling Pathway—CCL2—age related macular degeneration	0.0175	0.0175	CbGpPWpGaD
Amrinone—TNF—Apoptosis-related network due to altered Notch3 in ovarian cancer—APOE—age related macular degeneration	0.0172	0.0172	CbGpPWpGaD
Amrinone—TNF—Vitamin B12 Metabolism—CCL2—age related macular degeneration	0.0149	0.0149	CbGpPWpGaD
Amrinone—TNF—Folate Metabolism—CRP—age related macular degeneration	0.0148	0.0148	CbGpPWpGaD
Amrinone—TNF—Transcriptional regulation of white adipocyte differentiation—CD36—age related macular degeneration	0.0145	0.0145	CbGpPWpGaD
Amrinone—TNF—Regulation of toll-like receptor signaling pathway—SQSTM1—age related macular degeneration	0.0135	0.0135	CbGpPWpGaD
Amrinone—TNF—Allograft Rejection—C3—age related macular degeneration	0.0135	0.0135	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—CST3—age related macular degeneration	0.0128	0.0128	CbGpPWpGaD
Amrinone—TNF—MAPK Signaling Pathway—TGFBR1—age related macular degeneration	0.0128	0.0128	CbGpPWpGaD
Amrinone—TNF—Alzheimers Disease—APOE—age related macular degeneration	0.0125	0.0125	CbGpPWpGaD
Amrinone—TNF—Folate Metabolism—CCL2—age related macular degeneration	0.0122	0.0122	CbGpPWpGaD
Amrinone—TNF—Selenium Micronutrient Network—CRP—age related macular degeneration	0.0117	0.0117	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—TGFBR1—age related macular degeneration	0.0115	0.0115	CbGpPWpGaD
Amrinone—TNF—Aryl Hydrocarbon Receptor—VEGFA—age related macular degeneration	0.0104	0.0104	CbGpPWpGaD
Amrinone—PDE3A—GPCR downstream signaling—RHO—age related macular degeneration	0.0101	0.0101	CbGpPWpGaD
Amrinone—TNF—Toll-like Receptor Signaling Pathway—TLR4—age related macular degeneration	0.01	0.01	CbGpPWpGaD
Amrinone—TNF—Selenium Micronutrient Network—CCL2—age related macular degeneration	0.00966	0.00966	CbGpPWpGaD
Amrinone—PDE4B—GPCR downstream signaling—RHO—age related macular degeneration	0.00961	0.00961	CbGpPWpGaD
Amrinone—TNF—TNF alpha Signaling Pathway—CCL2—age related macular degeneration	0.00932	0.00932	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—RHO—age related macular degeneration	0.00917	0.00917	CbGpPWpGaD
Amrinone—TNF—Spinal Cord Injury—TLR4—age related macular degeneration	0.0089	0.0089	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—RDH8—age related macular degeneration	0.00884	0.00884	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—RHO—age related macular degeneration	0.00872	0.00872	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—RDH8—age related macular degeneration	0.00841	0.00841	CbGpPWpGaD
Amrinone—TNF—Regulation of toll-like receptor signaling pathway—TLR4—age related macular degeneration	0.00781	0.00781	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—RPE65—age related macular degeneration	0.00773	0.00773	CbGpPWpGaD
Amrinone—TNF—Spinal Cord Injury—CCL2—age related macular degeneration	0.00764	0.00764	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—RPE65—age related macular degeneration	0.00735	0.00735	CbGpPWpGaD
Amrinone—TNF—Allograft Rejection—VEGFA—age related macular degeneration	0.00676	0.00676	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—ABCA4—age related macular degeneration	0.00623	0.00623	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—ABCA4—age related macular degeneration	0.00592	0.00592	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—CD36—age related macular degeneration	0.00545	0.00545	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—RHO—age related macular degeneration	0.00542	0.00542	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—RHO—age related macular degeneration	0.00515	0.00515	CbGpPWpGaD
Amrinone—TNF—SIDS Susceptibility Pathways—VEGFA—age related macular degeneration	0.00392	0.00392	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	0.00334	0.00334	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—CD36—age related macular degeneration	0.00328	0.00328	CbGpPWpGaD
Amrinone—PDE3A—GPCR downstream signaling—C3—age related macular degeneration	0.00327	0.00327	CbGpPWpGaD
Amrinone—PDE4B—GPCR downstream signaling—C3—age related macular degeneration	0.00311	0.00311	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—TGFBR1—age related macular degeneration	0.00304	0.00304	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—C3—age related macular degeneration	0.00297	0.00297	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—TGFBR1—age related macular degeneration	0.00289	0.00289	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—KDR—age related macular degeneration	0.00283	0.00283	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—C3—age related macular degeneration	0.00282	0.00282	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—SQSTM1—age related macular degeneration	0.00276	0.00276	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—SQSTM1—age related macular degeneration	0.00262	0.00262	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—VEGFA—age related macular degeneration	0.0026	0.0026	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—CCL2—age related macular degeneration	0.00232	0.00232	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—CCL2—age related macular degeneration	0.00221	0.00221	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—C3—age related macular degeneration	0.00175	0.00175	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—C3—age related macular degeneration	0.00167	0.00167	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—APOE—age related macular degeneration	0.00163	0.00163	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—KDR—age related macular degeneration	0.0016	0.0016	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—VEGFA—age related macular degeneration	0.00156	0.00156	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—APOE—age related macular degeneration	0.00155	0.00155	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—KDR—age related macular degeneration	0.00152	0.00152	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—CCL2—age related macular degeneration	0.00137	0.00137	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—CCL2—age related macular degeneration	0.0013	0.0013	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—VEGFA—age related macular degeneration	0.00088	0.00088	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—VEGFA—age related macular degeneration	0.000837	0.000837	CbGpPWpGaD
